China is planning to revise safety standards governing multiple processed foods and nutritional ingredients in its latest initiative to battle food contamination and adulteration in the country.
Canadian contract research organization Nutrasource has completed an expansion to its on-site clinic that it says will enable the company to conduct a wide variety of trials.
The incidence of Milk Thistle material that contains little or no silymarin (the active constituents) is ‘relatively high’ and represents an ‘ongoing problem’, according to a new bulletin from the ABC-AHP-NCNPR Botanical Adulterants Prevention Program...
“We cannot enforce against what we cannot see or cannot know is there”, said FDA’s Steven Tave, and that’s why mandatory listing requirement for dietary supplement products would be a step forward for enforcement.
As sales of dietary supplements and natural products remain high – and many companies report record sales – the strain on the supply chain is immense, and for botanicals in particular, and that means a difficult 2021 could be on the horizon.
An Arizona-based algae company is building on work done by a predecessor to bring an EPA-rich supplement ingredient to market. The company says an additional facility that will bring it to commercial scale will be completed by the end of this year.
GW Pharmaceuticals and supplement retailer GNC have reportedly been among the companies meeting recently with a White House division to discuss aspects of CBD regulation.
It was hard enough keeping everyone on the same compliance page and then along came COVID-19. During the pandemic, FDA has published dozens of guidance documents for the dietary supplement industry as well as other stakeholders.
Nutraveris, a software firm that consults on regulatory affairs for nutrition and dietary supplement markets in Europe, has announced that they have launched an online platform for supplement compliance in the United States.
A new paper from a prominent industry critic has found a number of unapproved drugs in a suite of cognitive and memory support products purchased online.
Testing done by supplement manufacturer Nature’s Way and publicized by the American Botanical Council further solidifies the notion that adulteration of elderberry products is on the rise.
A ‘Regulatory Gap’ exists within the US dietary supplements industry, and recent talk of modernizing the regulations are ways to close that gap, FDA’s Steven Tave said yesterday
The recent upheavals in the United States around race relations has the nation questioning the insidious role prejudice has played in many walks of life. One group is seeking to use that rekindled awareness as added leverage to ensure equal opportunity...
Dietary supplement manufacturer Pharmavite has filed a RICO lawsuit against the Clean Label Project, alleging that the organization’s testing and product grading activities amount to a protection racket.
A nonprofit group has asked FDA to crack down on the sale of tianeptine, an ingredient that is sold as an antidepressant drug in many markets outside of the United States.
An inspection and review conducted by South Korea’s authorities found that most of the supplements of questionable quality being sold only were from US brands.
The hemp/CBD industry may have gotten the cart before the horse in terms of extraction capacity and raw material supply, said an investment analyst familiar with the sector.
An upcoming symposium will explore the toxicology, pharmacokinetics, analysis, and regulatory perspectives of pyrrolizidine alkaloids, toxic compounds that may be found in food and herbal products.
Interest in personalized nutrition is surging, increasing more than threefold between 2017 and 2019. With more than a billion people worldwide diagnosed with diet-related diseases, costs for their care has jumped to more than $1 trillion dollars a year....
Nascent hemp/CBD firms are often woefully unprepared for the regulatory compliance side of operating a dietary supplement firm, something an upcoming industry event aims to help fix.
New York-based Gemini Pharmaceuticals has achieved International Standard ISO/IEC 17025:2017 accreditation for Testing Laboratory from ANSI National Accreditation Board (ANAB) for its in-house analytical laboratory.
The US Food and Drug Administration may be willing to sit down with a company about a possible NDI submission for full-spectrum hemp extracts, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).
An amendment to a military funding bill would make it possible for military personnel to openly use hemp/CBD products for the first time. While advocates welcome the development, there is little prospect that CBD products will become part of standard...
FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.
Clorox, a major manufacturer of dietary supplements and household products, has partnered with the Cleveland Clinic on a guide to help businesses cope with coronavirus provisions in the workplace.
Making nutrition understandable for everyone is the goal of the Label Wise initiative led by the Council for Responsible Nutrition. That made it a clear choice for this year’s Editors Award for Industry Initiative of the Year.
An additional seven supplement companies have been added recently to the US Food and Drug Administration’s list of firms making allegedly non compliant COVID-19 treatment claims.
Suzanne Shelton, a winner of a NutraIngredients-USA NutraChampion 2020 award, took an alternative path early in life as a groundbreaking Chicago DJ and rode that rhythm into becoming one of the leading voices within the natural products industry.
After pausing on-site surveillance inspections in March, the Food and Drug Administration plan to resume domestic inspections starting the week of July 20.
Recent cyberattacks on a contract lab and a contract manufacturer lay bare the risk all data-based businesses run in a globalized world where threats can come from anywhere and can potentially be motivated by factors beyond mere financial gain.
A new publication from the Botanical Adulterants Prevention Program reveals that as many as 90% of the lavender essential oil products on the market can be considered to be adulterated.
An FDA report on the CBD marketplace reveals that many of the products tested contain THC that was not identified on the labels. In addition, a majority of the products did not meet label claim for CBD content, with either too little or too much CBD.
The bioactivity of commercial bovine colostrum samples may vary significantly, says a new study partially funded by colostrum-based nutrition company, PanTheryx, which the company says aims to shine a spotlight on sourcing and handling.
A recent warning letter reiterates the importance of collecting adverse event reports in order to demonstrate full compliance with federal laws governing the manufacture and sale of dietary supplements.
A contract manufacturer has received a warning letter for manufacturing products containing the stimulant DMHA, which was the subject of a concerted FDA enforcement action in 2019.
California-based Alkemist Labs has again achieved accreditation to the requirements of ISO/IEC 17025:2017, but this time the accreditation includes the lab’s internally developed cannabinoids and terpenes assays.
Certifications will be an increasingly important part of the future sports nutrition marketplace, says PLT Health Solutions as it announces a new verification of one of its new ingredients.
A judge has approved a permanent injunction order against the principals of a dietary supplement company who allegedly repeatedly ignored FDA warnings and inspection findings on illegal disease claims and other violations.
A new stakeholder group has come together to push for quality and transparency in the dietary supplement industry. Called the Dietary Supplement Quality Collaborative (DSQC), the group published a policy paper recently as part of its public debut.
Alkemist Labs' CEO Elan Sudberg says he's seen evidence that some ingredient suppliers and marketing companies have been altering valid lab reports and using those falsified reports to promote their products.
Supplement manufacturer NOW reports that among CoQ10 and SAMe products it purchased recently on Amazon and subjected to analytical testing, only a few came close to meeting label claim for the amount of active ingredients, while most had little or none...
